Frailty, multimorbidity and polypharmacy: exploratory analyses of the effects of empagliflozin from the EMPA-KIDNEY trial

Mayne K., HERRINGTON W.

Type

Journal article

Publisher

American Society of Nephrology

Publication Date

2024-06-25T00:00:00+00:00

Permalink Close